Resverlogix Corp. (TSE:RVX – Get Free Report) shares crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.05 and traded as high as C$0.05. Resverlogix shares last traded at C$0.05, with a volume of 11,000 shares.
Resverlogix Stock Performance
The company has a 50-day moving average price of C$0.05 and a 200-day moving average price of C$0.06. The firm has a market capitalization of C$13.74 million, a price-to-earnings ratio of -0.63 and a beta of 0.69.
About Resverlogix
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- Stock Average Calculator
- 3 AI Stocks That You Can Buy and Hold Forever
- What is the S&P/TSX Index?
- As The Magnificent 7 Stumble, Pivot to These 3 Growth Stocks
- How to Evaluate a Stock Before BuyingÂ
- Joby Aviation Stock: The Case for Upside Just Got Stronger
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
